Clinical trials in Ukraine – a first hand perspective

Damage to infrastructure, supply chain disruption, patient and researcher safety – conflict in Ukraine has forced clinical trial organisers to adapt quickly. Thanks to their ingenuity, and the resilience of their Ukrainian partners, the country’s clinical trial map is getting back on track. Through new partnerships with labs in neighbouring countries, flexibility for rules on treatments and new road routes for importing and exporting materials, the freeze on research thawed virtually overnight. In this webinar, Oximio – who have handled thousands of shipments for dozens of sponsors over the course of the conflict – analyse the legal and logistical transformation. Led by first-hand expertise from the company’s Ukraine team, they explain the key factors in enabling clinical trials to start and resume. Fill in your details to find out more.